Huron Consulting Group (NASDAQ:HURN) Rating Reiterated by Benchmark

Huron Consulting Group (NASDAQ:HURN)‘s stock had its “buy” rating reaffirmed by equities researchers at Benchmark in a research note issued on Wednesday, Benzinga reports. They presently have a $140.00 price objective on the business services provider’s stock. Benchmark’s target price points to a potential upside of 28.62% from the company’s current price.

HURN has been the topic of a number of other research reports. Wedbush restated an “outperform” rating and set a $110.00 price target on shares of Huron Consulting Group in a report on Thursday, May 23rd. Barrington Research restated an “outperform” rating and set a $133.00 price target on shares of Huron Consulting Group in a report on Tuesday, May 28th. StockNews.com downgraded Huron Consulting Group from a “hold” rating to a “sell” rating in a report on Friday, July 26th. Finally, Truist Financial restated a “buy” rating and set a $140.00 price target on shares of Huron Consulting Group in a report on Thursday, May 16th. One investment analyst has rated the stock with a sell rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $130.75.

Huron Consulting Group Stock Performance

Shares of Huron Consulting Group stock traded down $4.08 during trading hours on Wednesday, reaching $108.85. The company had a trading volume of 289,969 shares, compared to its average volume of 139,001. Huron Consulting Group has a one year low of $84.26 and a one year high of $115.65. The business has a fifty day simple moving average of $98.36 and a 200 day simple moving average of $97.51. The company has a debt-to-equity ratio of 1.13, a current ratio of 2.40 and a quick ratio of 2.40. The firm has a market cap of $1.96 billion, a PE ratio of 31.42 and a beta of 0.61.

Huron Consulting Group (NASDAQ:HURN) last posted its quarterly earnings data on Tuesday, July 30th. The business services provider reported $1.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.48 by $0.20. Huron Consulting Group had a return on equity of 19.21% and a net margin of 4.67%. The company had revenue of $371.70 million during the quarter, compared to analyst estimates of $374.33 million. During the same quarter last year, the company earned $1.38 earnings per share. The firm’s quarterly revenue was up 7.2% on a year-over-year basis. On average, analysts anticipate that Huron Consulting Group will post 5.83 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Huron Consulting Group news, CEO C. Mark Hussey sold 34,013 shares of the company’s stock in a transaction that occurred on Friday, July 12th. The stock was sold at an average price of $100.69, for a total transaction of $3,424,768.97. Following the transaction, the chief executive officer now owns 85,081 shares in the company, valued at approximately $8,566,805.89. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, Director John Mccartney sold 1,259 shares of the company’s stock in a transaction that occurred on Tuesday, June 11th. The stock was sold at an average price of $95.38, for a total value of $120,083.42. Following the transaction, the director now directly owns 57,988 shares of the company’s stock, valued at approximately $5,530,895.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO C. Mark Hussey sold 34,013 shares of the company’s stock in a transaction that occurred on Friday, July 12th. The shares were sold at an average price of $100.69, for a total value of $3,424,768.97. Following the completion of the transaction, the chief executive officer now directly owns 85,081 shares in the company, valued at $8,566,805.89. The disclosure for this sale can be found here. In the last quarter, insiders have sold 35,872 shares of company stock worth $3,601,300. Company insiders own 2.02% of the company’s stock.

Hedge Funds Weigh In On Huron Consulting Group

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Principal Securities Inc. purchased a new stake in Huron Consulting Group during the 4th quarter valued at $25,000. Covestor Ltd boosted its holdings in shares of Huron Consulting Group by 26,500.0% during the 1st quarter. Covestor Ltd now owns 266 shares of the business services provider’s stock valued at $26,000 after purchasing an additional 265 shares during the last quarter. International Assets Investment Management LLC bought a new position in shares of Huron Consulting Group during the 4th quarter valued at about $42,000. Quest Partners LLC purchased a new position in Huron Consulting Group in the fourth quarter worth about $97,000. Finally, Headlands Technologies LLC grew its position in Huron Consulting Group by 2,020.0% in the fourth quarter. Headlands Technologies LLC now owns 954 shares of the business services provider’s stock worth $98,000 after acquiring an additional 909 shares in the last quarter. 93.90% of the stock is owned by institutional investors.

Huron Consulting Group Company Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.